Skip to main content

Deerfield Management leads $40 million funding round for Baltimore’s Dracen Pharmaceuticals – Baltimore Business Journal

By March 24, 2018News
deerfield-management-logo

deerfield-management-logo

New York-based investment firm Deerfield Management is leading a $40 million Series A funding round for Baltimore’s Dracen Pharmaceuticals Inc.

{iframe}https://www.bizjournals.com/baltimore/news/2018/03/22/health-care-focused-deerfield-management-leads.html?ana=e_ae_set2&s=article_du&ed=2018-03-22&u=wjGEy67ABoSnsLErlc5ry0j5hx3&t=1521855902&j=80637871{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.